DnB NOR Asset Management AS »

4d Molecular Therapeutics In shares owned by DnB NOR Asset Management AS

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by DnB NOR Asset Management AS from 13F filings

Historical chart of DnB NOR Asset Management AS investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by DnB NOR Asset Management AS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by DnB NOR Asset Management AS

Quarter filed Position value Share count Share price at filing
2024-03-31 $234k 7.4k 31.84

More positions owned by DnB NOR Asset Management AS

Microsoft Corp common (MSFT)
Meta Platforms common (META)
Alphabet Inc - A common (GOOGL)
Nvidia Corp common (NVDA)
Apple common (AAPL)
Amazon.Com common (AMZN)
Western Digital Corp common (WDC)
Visa common (V)
Mastercard common (MA)
Check Point Software Technologies common
Oracle Corp common (ORCL)
Eli Lilly & Co common (LLY)
Qualcomm common (QCOM)
JPMorgan Chase & Co common (JPM)
Electronic Arts common (EA)

View all positions for DnB NOR Asset Management AS

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In